British Journal of Clinical Pharmacology · 1993 · 15 citations · 9 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacodynamicsBlood Pressure ControlBlood Pressure ManagementBlood Pressure RegulationHypertension ControlHypertension ManagementHypertension PharmacotherapyBlood PressurePlasma Renin ActivityRas Pathway ActivationRenin-angiotensin System BlockadeRenin-angiotensin System InhibitorsRenin-angiotensin-aldosterone System ActivationRenin-angiotensin-aldosterone System InhibitorsSupine Hypertension
A combination of dietary sodium restriction (40 mmol day-1) and frusemide pretreatment has been used to activate the renin angiotensin system (RAS) in order to characterise the haemodynamic and hormonal responses to enalapril in young normotensives. Enalapril significantly reduced supine blood pressure with a mean maximum fall of 19 +/- 7.6, compared with 6.5 +/- 6.8 mm Hg with placebo. Similar but greater responses were seen in erect blood pressure. Mean maximal plasma ACE inhibition (78 +/- 5.7%) was associated with a significant increase in PRA from 5.2 +/- 2.1 ngAI ml-1 h-1 to a peak of 29.1 +/- 6 ngAI ml-1 h-1. This simple well tolerated regimen produced consistent RAS activation and gave readily measurable falls in blood pressure following enalapril. This model may be used to undertake detailed assessments of ACE inhibition, renin inhibition and angiotensin receptor blockade.
9
Factors related to first dose hypotensive effect of captopril: prediction and treatment.
G P Hodsman, C. Isles, Gordon Murray et al. · BMJ · 1983 · 137 citations · Full text